- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11:46 | Brii Biosciences and Joincare sign licence agreement for BRII-693 | ||
| Do | Theratechnologies shares surge 25% amid $254m Future Pak takeover | ||
| Do | UK Government reveals 10-year plan for NHS | ||
| Do | BioVersys and Shionogi agree to develop ansamycin leads | ||
| Do | Regeneron nabs dosing edge with Lynozyfic's FDA approval in multiple myeloma | ||
| Do | Ligand's LNHC concludes merger with CHRO | ||
| Do | Navigating the AI regulatory maze: Why 91% of life sciences professionals feel lost | ||
| Do | Podcast: The importance of Social Determinants of Health (SDoH) | ||
| Do | FDA approves Dizal's Zegfrovy to treat adults with NSCLC | ||
| Do | Protecting patients' data is vital for NHS single health record system | ||
| Mi | Analysis shows Yeztugo approval a 'momentous step' for HIV prevention | ||
| Mi | Sanofi agrees to invest $25m in Adagene | ||
| Mi | Trump tax bill estimated to cut Medicaid spend by $1trn passes US Senate | ||
| Mi | Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold | ||
| Mi | Merck concludes SpringWorks acquisition for $3.4bn | ||
| Mi | Cell and gene therapy: The vital role of logistics | ||
| Mi | Uruguay progresses towards developing its first regulatory agency | ||
| Mi | EC approves Jazz Pharmaceuticals' Ziihera for biliary tract cancer | ||
| Di | Oncternal sells assets for up to $68m and calls it quits | ||
| Di | Sanofi's riliprubart gains ODD status from Japan's MHLW for CIDP | ||
| Di | EU's Pharma Package falls short of Europe's goal of global competitiveness | ||
| Di | AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline | ||
| Di | Piramal Pharma announces $90m investment to expand US sites | ||
| Mo | WHO accuses China of withholding Covid-19 genetic data | ||
| Mo | US trade tariffs and the potential impact on pharma supply chains |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .